Discovery of serum biomarkers for pancreatic adenocarcinoma using proteomic analysis.
about
Apolipoprotein A-II Plus Lipid Emulsion Enhance Cell Growth via SR-B1 and Target Pancreatic Cancer In Vitro and In VivoSerum cytokine biomarker panels for discriminating pancreatic cancer from benign pancreatic disease.Salivary glycopatterns as potential biomarkers for diagnosis of gastric cancerProteomic analysis of urinary upper gastrointestinal cancer markers.New serum biomarkers for detection of tuberculosis using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.SELDI-TOF-MS proteomic profiling of serum, urine, and amniotic fluid in neural tube defects.Metabolomics study of stepwise hepatocarcinogenesis from the model rats to patients: potential biomarkers effective for small hepatocellular carcinoma diagnosis.Identification of apolipoprotein C-I as a potential Wilms' tumor marker after excluding inflammatory factorsSerum apolipoprotein C-II is prognostic for survival after pancreatic resection for adenocarcinomaIdentification and verification of transthyretin as a potential biomarker for pancreatic ductal adenocarcinoma.Advances in biomarker research for pancreatic cancer.Pancreatic Cancer: a Challenge to CurePancreatic preneoplastic lesions plasma signatures and biomarkers based on proteome profiling of mouse models.Serum biomarkers identification by mass spectrometry in high-mortality tumors.Prediction of metastasis and recurrence in colorectal cancer based on gene expression analysis: ready for the clinic?Discrimination between adenocarcinoma and normal pancreatic ductal fluid by proteomic and glycomic analysis.Molecular pathology of pancreatic cancer: from bench-to-bedside translation.Diagnostic, prognostic, and predictive biomarkers in pancreatic cancer.Breast cancer biomarkers: proteomic discovery and translation to clinically relevant assays.Screening technologies for target identification in pancreatic cancer.Potential usefulness of apolipoprotein A2 isoforms for screening and risk stratification of pancreatic cancer.Proteome-based biomarkers in pancreatic cancer.
P2860
Q28550931-8E06F29F-5950-4904-8FB4-C1A17154EFAAQ33655712-511342C7-59C2-48D0-97A0-9A5CEB6F87D0Q33829287-56694114-FEEF-4E00-B052-5EF05FE67F8DQ33888474-59333B0A-BC6B-4E5B-A8D0-4D925A5B7B1EQ33932020-4B772610-0B06-4F39-B3DF-9A5E49BF931FQ33940289-CF38EE2C-114E-4692-89DA-0F8D2A93067CQ34074566-4EF4214B-3EAA-4DD0-965C-27E6870141E9Q34358608-88C20A23-8410-4D12-B932-9BB566E7301EQ34483897-1142123F-77C0-4A4A-8F10-E7996A1AD48CQ34644418-A4708DAF-AC82-47DA-9D25-79BFF882846BQ36126609-31C21EA7-474E-4804-83F1-16093F821256Q36400081-BB054900-578D-4E84-9DF4-33B06CC122D5Q36443870-63910D59-FAF7-4E80-882A-DD7FD04970CAQ36582422-10BCE8A5-53B4-466F-84A5-1E5420D10970Q37137352-86783B3A-4835-4EAA-B542-7A67D33F8351Q37624230-37318D55-8AB8-4AA2-BF14-EC53FB83FAFDQ37998096-1E63BECA-0AAA-4C13-997C-3402CC70763FQ38021384-E6B7DE38-62C9-4DC0-9A34-00C965A06EE6Q38068925-832471B8-9495-4CF2-B3D4-0F959C608AAFQ38161327-E6118FBC-FC51-42C8-A555-FAC7E55E8345Q38965713-C454800C-5B0A-4AC6-83C9-2CB7B3E93C0FQ43008803-D12456DD-22FE-4B84-A8A1-97F5302E4BAA
P2860
Discovery of serum biomarkers for pancreatic adenocarcinoma using proteomic analysis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Discovery of serum biomarkers for pancreatic adenocarcinoma using proteomic analysis.
@ast
Discovery of serum biomarkers for pancreatic adenocarcinoma using proteomic analysis.
@en
type
label
Discovery of serum biomarkers for pancreatic adenocarcinoma using proteomic analysis.
@ast
Discovery of serum biomarkers for pancreatic adenocarcinoma using proteomic analysis.
@en
prefLabel
Discovery of serum biomarkers for pancreatic adenocarcinoma using proteomic analysis.
@ast
Discovery of serum biomarkers for pancreatic adenocarcinoma using proteomic analysis.
@en
P2093
P2860
P50
P356
P1476
Discovery of serum biomarkers for pancreatic adenocarcinoma using proteomic analysis
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BJC.6605764
P407
P577
2010-06-29T00:00:00Z
P5875
P6179
1001713141